Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Ulcerative colitis Age: Adult Condition: Acute attack of mild to moderate ulcerative colitis |
Dose: Delayed Release Tablet (400 mg) – 2.4 g Frequency: daily in divided doses |
|
Indication: Ulcerative colitis Age: Adult Condition: Maintenance of remission of ulcerative colitis |
Dose: Delayed Release Tablet (400 mg) – 1.2–2.4 g Frequency: daily in divided doses |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Ulcerative colitis Condition: Acute attack (mild to moderate) |
Dose: Delayed Release (DR) Tablet (400mg) – 800 mg Frequency: three times daily |
|
Indication: Ulcerative colitis Condition: Maintenance of remission |
Dose: Delayed Release (DR) Tablet (400mg) – 400–800 mg Frequency: two to three times daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment with Creatinine Clearance less than 20 ml/min |
Dose: dosage form not mentioned – dose not mentioned Note: Avoid |
|
Condition: Renal function deteriorates while in therapy |
Dose: dosage form not mentioned – dose not mentioned Note: Discontinue use |
Administration
- <p>
- Can be taken with or without food
Side Effect
- Abdominal pain (4-8%)
- GI discomfort (4-[..449/569..]ome
- Hypersensitivity reactions
- Hepatic failure
- Less than /pMore than
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Lactulose
|
Prevents release of mesalazine
|
|
Digoxin
|
May decrease absorption
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe Renal Impairment
|
GFR less than 30 mL per minute Monitor for general drug reactions can cause further kidney damage
|
|
Severe Liver Impairment
|
Can worsen liver function
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30 0 C. Protect from light and moisture. Keep all medicines out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.